Citations (18)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (1)
Vito Di Lernia, Cinzia Ricci, Aimilios Lallas & Elena Ficarelli. (2014) Clinical predictors of non-response to any tumor necrosis factor (TNF) blockers: a retrospective study. Journal of Dermatological Treatment 25:1, pages 73-74.
Read now
Read now
Articles from other publishers (17)
Cervantes-Durán Claudia, Velázquez-Hernández María-Elena, Valentín-Escalera Josué, Bartolomé-Camacho María-Carmen, Rodríguez-Orozco Alain-Raimundo & García-Pérez Martha-Estrella. (2020) Small molecules under development for psoriasis: on the road to the individualized therapies. Archives of Dermatological Research 312:9, pages 611-627.
Crossref
Crossref
Zandra C. Félix GarzaJoerg LiebmannMatthias BornPeter A.J. HilbersNatal A.W. van Riel. (2019)
In Silico
Clinical Studies on the Efficacy of Blue Light for Treating Psoriasis in Virtual Patients
. Systems Medicine 2:1, pages 10-18.
Crossref
Crossref
Sara Redenšek & Vita Dolžan. 2017. An Interdisciplinary Approach to Psoriasis. An Interdisciplinary Approach to Psoriasis.
Rocío Prieto-Pérez, Mar Llamas-Velasco, Teresa Cabaleiro, Guillermo Solano-López, Beatriz Márquez, Manuel Román, Dolores Ochoa, María Talegón, Esteban Daudén & Francisco Abad-Santos. (2017) Pharmacogenetics of ustekinumab in patients with moderate-to-severe plaque psoriasis. Pharmacogenomics 18:2, pages 157-164.
Crossref
Crossref
Anamika Das, Aditi Chandra, Anirudhya Lahiri, Shalini Datta, Swapan Senapati & Raghunath Chatterjee. 2005. Encyclopedia of Life Sciences. Encyclopedia of Life Sciences
1
9
.
Marco Galluzzo, Andreea Nicoleta Boca, Elisabetta Botti, Concetta Potenza, Giovanna Malara, Piergiorgio Malagoli, Stefan Vesa, Sergio Chimenti, Anca Dana Buzoianu, Marina Talamonti & Antonio Costanzo. (2016) IL12B (p40) Gene Polymorphisms Contribute to Ustekinumab Response Prediction in Psoriasis. Dermatology 232:2, pages 230-236.
Crossref
Crossref
C. De Simone, M. Farina, A. Maiorino, C. Fanali, F. Perino, A. Flamini, G. Caldarola & A. Sgambato. (2015)
TNF
‐alpha gene polymorphisms can help to predict response to etanercept in psoriatic patients
. Journal of the European Academy of Dermatology and Venereology 29:9, pages 1786-1790.
Crossref
Crossref
Yoshinori Umezawa, Hidehisa Saeki & Hidemi Nakagawa. (2014) Some clinical factors affecting quality of the response to ustekinumab for psoriasis. The Journal of Dermatology 41:8, pages 690-696.
Crossref
Crossref
Dimitrios Kapsokalyvas, Riccardo Cicchi, Nicola Bruscino, Domenico Alfieri, Francesca Prignano, Daniela Massi, Torello Lotti & Francesco S. Pavone. (2014) In-vivo imaging of psoriatic lesions with polarization multispectral dermoscopy and multiphoton microscopy. Biomedical Optics Express 5:7, pages 2405.
Crossref
Crossref
Sara BrennerDavid Schairer, MD Chouake, MD Nasir & Adam Friedman. 2013. The Clinical Nanomedicine Handbook. The Clinical Nanomedicine Handbook
85
194
.
Rocío Prieto-Pérez, Teresa Cabaleiro, Esteban Daudén, Dolores Ochoa, Manuel Román & Francisco Abad-Santos. (2013) Pharmacogenetics of topical and systemic treatment of psoriasis. Pharmacogenomics 14:13, pages 1623-1634.
Crossref
Crossref
E. Gallo, T. Cabaleiro, M. Román, G. Solano-López, F. Abad-Santos, A. García-Díez & E. Daudén. (2013)
The relationship between tumour necrosis factor (TNF)-α promoter and
IL12B
/
IL-23R
genes polymorphisms and the efficacy of anti-TNF-α therapy in psoriasis: a case-control study
. British Journal of Dermatology 169:4, pages 819-829.
Crossref
Crossref
Ashok Kumar GuptaShyam Sunder PandeyBajrangprasad Laxminarayan Pandey. (2013) Effectiveness of Conventional Drug Therapy of Plaque Psoriasis in the Context of Consensus Guidelines: A Prospective Observational Study in 150 Patients. Annals of Dermatology 25:2, pages 156.
Crossref
Crossref
R.T. Woolf, S.L. West, M. Arenas-Hernandez, N. Hare, A.M. Peters van Ton, C.M. Lewis, A.M. Marinaki, J.N.W.N Barker & C.H. Smith. (2012) Methotrexate polyglutamates as a marker of patient compliance and clinical response in psoriasis: a single-centre prospective study. British Journal of Dermatology 167:1, pages 165-173.
Crossref
Crossref
William R. Swindell, Xianying Xing, Philip E. Stuart, Cynthia S. Chen, Abhishek Aphale, Rajan P. Nair, John J. Voorhees, James T. Elder, Andrew Johnston & Johann E. Gudjonsson. (2012) Heterogeneity of Inflammatory and Cytokine Networks in Chronic Plaque Psoriasis. PLoS ONE 7:3, pages e34594.
Crossref
Crossref
Laura Di Renzo, Alessia Bianchi, Rosita Saraceno, Vittorio Calabrese, Caroline Cornelius, Leonardo Iacopino, Sergio Chimenti & Antonino De Lorenzo. (2012) −174G/C IL-6 gene promoter polymorphism predicts therapeutic response to TNF-α blockers. Pharmacogenetics and Genomics 22:2, pages 134-142.
Crossref
Crossref
Yiannis Vasilopoulos, Marilena Manolika, Efterpi Zafiriou, Theologia Sarafidou, Vasilis Bagiatis, Sabine Krüger-Krasagaki, Androniki Tosca, Aikaterini Patsatsi, Dimitris Sotiriadis, Zissis Mamuris & Angeliki Roussaki-Schulze. (2012) Pharmacogenetic Analysis of TNF, TNFRSF1A, and TNFRSF1B Gene Polymorphisms and Prediction of Response to Anti-TNF Therapy in Psoriasis Patients in the Greek Population. Molecular Diagnosis & Therapy 16:1, pages 29-34.
Crossref
Crossref